SOURCES SOUGHT-NEW CONTRACEPTIVE PRODUCTS

NIH GUIDE, Volume 26, Number 40, December 19, 1997

P.T.

National Institute of Child Health and Human Development

The Contraceptive Development Branch of the Center for Population Research,
National Institute of Child Health and Human Development (NICHD)is interested
in receiving letters of interest regarding new or improved male or female
contraceptives which are ready for clinical testing for possible safety,
acceptability, and/or efficacy testing in our Contraceptive Clinical Trials
Network (a network of nine clinical testing sites).  Only reversible methods
of contraception are being considered at this time.  Candidate drugs or
devices include but are not limited to chemical or physical barrier methods,
hormonal contraceptives, and intrauterine devices.  Interested organizations
should submit a letter of interest which contains a detailed description of
the product and summarized results of any preclinical or clinical testing. 
Letters of interest will be kept confidential.  After initial screening,
organizations with promising products will be contacted for further
information.  This is a continuing announcement with no specific due date.

INQUIRIES

Submit your response to the address listed below:

Paul J. Duska
Contracts Management Branch
National Institute of Child Health and Human Development
6100 Executive Boulevard, Suite 7A07
Bethesda, MD  20892-7510
FAX:  (301) 402-3676

Return to Volume Index

Return to 1997 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.